Genovis AB (Sweden) Analysis
| GENO Stock | SEK 28.05 0.85 3.13% |
Genovis AB is overvalued with Real Value of 21.54 and Hype Value of 27.2. The main objective of Genovis AB stock analysis is to determine its intrinsic value, which is an estimate of what Genovis AB is worth, separate from its market price. There are two main types of Genovis AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Genovis AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Genovis AB's stock to identify patterns and trends that may indicate its future price movements.
The Genovis AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Genovis AB is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Genovis Stock trading window is adjusted to Europe/Stockholm timezone.
Genovis |
Genovis Stock Analysis Notes
About 24.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 976.19. Genovis AB had not issued any dividends in recent years. The entity had 1:10 split on the 4th of April 2012. Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20 people. To learn more about Genovis AB call Fredrik Olsson at 46 46 10 12 30 or check out https://www.genovis.com.Genovis AB Investment Alerts
| Genovis AB had very high historical volatility over the last 90 days | |
| About 24.0% of the company shares are held by company insiders |
Genovis Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genovis AB's market, we take the total number of its shares issued and multiply it by Genovis AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Genovis Profitablity
Genovis AB's profitability indicators refer to fundamental financial ratios that showcase Genovis AB's ability to generate income relative to its revenue or operating costs. If, let's say, Genovis AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Genovis AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Genovis AB's profitability requires more research than a typical breakdown of Genovis AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.34 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26. Technical Drivers
As of the 22nd of November, Genovis AB retains the Risk Adjusted Performance of 0.0619, downside deviation of 2.68, and Market Risk Adjusted Performance of (1.87). Genovis AB technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Genovis AB Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Genovis AB middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Genovis AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Genovis AB Outstanding Bonds
Genovis AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genovis AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genovis bonds can be classified according to their maturity, which is the date when Genovis AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Genovis AB Predictive Daily Indicators
Genovis AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genovis AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Genovis AB Forecast Models
Genovis AB's time-series forecasting models are one of many Genovis AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genovis AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Genovis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Genovis AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genovis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genovis AB. By using and applying Genovis Stock analysis, traders can create a robust methodology for identifying Genovis entry and exit points for their positions.
Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genovis AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Additional Tools for Genovis Stock Analysis
When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.